Germline mutations predisposing to melanoma

Area of Science:

• Genetics
• Oncology
• Dermatology

Background:

• Approximately 15% of melanomas occur in individuals with a family history of the disease.
• A subset of these patients harbor germline mutations in melanoma predisposition genes.
• While CDKN2A mutations are the most common cause of hereditary melanoma, numerous other susceptibility genes have been identified.

Purpose of the Study:

• To review the clinical and histopathologic features of melanocytic tumors associated with germline mutations.
• To discuss the role of genetic counseling in managing hereditary melanoma.
• To highlight the expanding landscape of genes implicated in hereditary melanoma beyond CDKN2A.

Main Methods:

• Literature review of clinical and histopathologic characteristics of melanocytic tumors.
• Analysis of genetic data related to melanoma predisposition genes.
• Discussion of diagnostic clues and genetic counseling implications.

Main Results:

• Germline mutations in genes including CDK4, TERT, ACD, TERF2IP, POT1, MITF, MC1R, and BAP1 contribute to hereditary melanoma.
• Increased melanoma risk is also observed in mixed cancer syndromes due to mutations in PTEN, BRCA2, BRCA1, RB1, and TP53.
• Clinical indicators like early onset, multiple tumors, family history, and epithelioid cytology can suggest specific genetic mutations (e.g., BAP1).

Conclusions:

• Hereditary melanoma is associated with a growing list of germline mutations.
• Clinical presentation and tumor histopathology are vital for identifying at-risk individuals.
• Genetic counseling plays a key role in risk assessment and management of hereditary melanoma.